RCC-FG2

Zellname

Beschreibung

Bestell-Nr.

Einheit

Preis, Euro

RCC-FG2

Humane Niere Klarzell-Karzinom Zell-Linie

300249

cryovial

375,00

RCC-FG2

Humane Niere Klarzell-Karzinom Zell-Linie

330249

vital

465,00



Designation:RCC-FG2 (KTCTL-26A)
Depositor:Pomer S. / CLS, 1999
Organism:Homo sapiens (human)
Ethnicity:Caucasian
Age/Stage:69 years
Gender:male
Tissue:kidney
Morphology:epithelial
Celltype:clear cell carcinoma pT2a, Nx, M1/GII
Growth Properties:monolayer
Description:Established from the kidney clear cell carcinoma of a 69-years-old-male, pT2a, Nx, M1/ GII; 1999; HLA-A2 positive; PAS positive, G250 positive
Culture Medium:RPMI 1640 medium supplemented with 5.1 ml L-glutamine (200 mM) and 10% fetal bovine serum.
Subculturing:Remove medium and rinse with 0.02% EDTA(versene) solution. Add fresh 0.025% trypsin/0.02% EDTA(versene) solution and let the culture sit at 37°C until the cells detach. Add fresh medium, aspirate and dispense into new flasks. Subculture every 3 to 6 days.
Split Ratio:A ratio of 1:2 to 1:3 is recommended
Fluid Renewal:1 to 2 times weekly
Freeze Medium:CM-1 (CLS · Cell Lines Service)
Sterility:Tests for mycoplasma, bacteria and fungi were negative
Biosafety Level:1
Tumorigenic:yes, in nude mice
Karyotype:Near-diploid range; partial loss of chromosome 3p (ie, 3p14), trisomy of chromosome 7
Immunology:cytokeratin 8+,18+, 19+; vimentin


References:

Hogernann I et al. Cytogenetic and growth factor gene analysis of a renal carcinoma cell line. Cancer Genet Cytogenet 78(2): 175-180, 1994.
Kopf-Maier P et al. The alkylator treosulfan shows activity towards human renal-cell carcinoma in vivo and in vitro. In Vivo 12(3): 275-288, 1998.
Kopf-Maier P et al. Antitumor activity of titanocene dichloride in xenografted human renal-cell carcinoma. Anticancer Res 19(1A): 493-504, 1999.

 

  Change language: eng        Diese Seite drucken   Sitemap   Kontakt  


 
top